The investment comes from an Akron-based investment firm, and the company has received 510(k) approval from the FDA to begin marketing its back-pain device. The device identifies pain points in the back by looking at electrical activity.
It also delivers electrical stimulation on the patient’s skin close to the identified pain points.
Related Articles About Pain Management:
Study: Hippocampus Suppresses Pain During Stress
Comparison of Pain Symptoms Reveals Treatment Implications
Doctor Identifies “Text Neck” as New Medical Condition
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
